Efamol

ETHICALLY SOURCED

Oils sourced in an ethical and sustainable way

PROVEN LEADERS

Leader in developing scientifically proven health supplements

EFAMOL PROMISE

We promise the highest purity and quality

FOR OVER 35 YEARS…

Efamol has led the international field in the scientific research and development of essential fatty acid (EFA) health supplements. Since its inception, Efamol has developed a specialised range of EFA-based products that span a number of health sectors, including heart, brain, eye, and hormonal health. Even our name demonstrates our commitment:

“Efamol” comes from the term Essential Fatty Acid MOLecule.

At Efamol, quality and purity are key values. The Efamol marine oil used in all the products is of superior standard and is harvested from sustainable stocks. As one of only a few international brands of EFA-based products, Efamol has led the way in developing scientifically proven health supplements.

THE EFAMOL STORY

The only true international brand of fatty acid-based products, Efamol has led the way in developing scientifically-proven essential fatty acid health supplements for over 35 years.

Late 1920s

Essential fatty acids (EFAs) were discovered, and the significant clinical research into their impact on human health began.

The 1950s

A group of researchers, including David Horrobin, published a scientific rationale indicating that Gamma-linolenic acid (GLA), derived from the seed of the evening primrose plant, could be beneficially linked to the quality of human health and nutrition.

1977

Efamol Pure Evening Primrose Oil was one of the first brands supplying high quality supplements for hormonal balance and skin health to be launched.

1981

The Efamol Research Institute is founded.

1995

The launch of Efalex pioneered the development of the brain and eye health category.

1999

Efamol was purchased by Royal Numico, a Dutch multi-national company with worldwide influence in the field of infant and clinical nutrition.

2003

Efamol was acquired by the current management team, a group of individuals with extensive experience in the field of essential fatty acid nutrition, and so returned to independent ownership.

2006

Efamol Biosciences Limited was acquired by a food supplement company, Wassen International Limited, to enable access to many more consumer markets across the globe.

2007

Efalex Active Memory was launched. A new formula combining omega-3 fish oil with key nutrients known for their beneficial role in maintaining healthy brain function and performance.

2009

Efalex re-launched as Efalex Omega-3 +6 in the UK.

2013

Efamol is launched in South Africa.

Tomorrow...

Preliminary planning is underway for the introduction of several new products, which goes hand-in-hand with an extension of research and development activities and a commitment to a comprehensive programme of clinical trials.

Efamol Quality

At Efamol, quality and purity are key values. The Efamol marine oil used in all the products is of superior standard and is harvested from sustainable stocks. As one of only a few international brands of EFA-based products, Efamol has led the way in developing scientifically-proven health supplements.

The EPA, DHA and AA (Eicosapentaenoic Acid, Docosahexaenoic Acid and Arachidonic Acid) found in our products, are all derived from marine oils, using carefully refined raw materials to ensure they are of the highest quality, and free of potentially harmful contaminants.

Fish oils vary in composition according to species, geographic origin and season. Efamol products use only fish body oils from wild (not farmed) fish, and they do not utilise liver oils. Efamol marine oils are tightly specified to ensure they contain the correct fatty acids in the correct ratios for their specific applications and are of the purest sources available. Each batch is routinely tested to ensure that it meets the company specifications and those set down by EU authorities.

In general, high DHA oils containing some AA are used in applications relating to development of learning, cognitive and visual systems, whereas high EPA oils are utilised in products for cardiovascular and inflammatory conditions.